Arcturus Therapeutics Stock Was 23.09% Up On Thursday

(VIANEWS) – The NASDAQ ended the session with Arcturus Therapeutics (ARCT) rising 23.09% to $23.88 on Thursday while NASDAQ jumped 0.07% to $14,103.84. Arcturus Therapeutics’s last close was $19.40, 48.61% below its 52-week high of $37.75. About Arcturus Therapeutics Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the…

Read More

Arcturus Therapeutics And Eli Lilly And Company On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Arcturus Therapeutics, Aspen Group, and Target Corporation. Rank Financial Asset Price Change Updated (EST) 1 Arcturus Therapeutics (ARCT) 23.88 23.09% 2023-11-15 12:15:37 2 Aspen Group…

Read More

Community Bank System, Orrstown Financial Services, Another 2 Companies Have A High Estimated Dividend Yield

(VIANEWS) – Community Bank System (CBU), Orrstown Financial Services (ORRF), Wells Fargo & Company (WFC) have the highest dividend yield stocks on this list. Financial Asset Forward Dividend Yield Updated (EST) Community Bank System (CBU) 4.29% 2023-11-13 19:07:05 Orrstown Financial Services (ORRF) 3.51% 2023-11-04 19:08:05 Wells Fargo & Company (WFC) 3.42% 2023-11-15 12:59:58 Qiagen N.V….

Read More

Target Stock Soars 16% – Is It Time To Buy?

(VIANEWS) – Target Corporation’s stock experienced an extraordinary 16.66% gain to close at EUR129.25 on Wednesday, following two consecutive sessions of gains and NYSE’s 0.36% upswing to EUR15,788.92. Despite the recent upswing, Target Corporation’s shares remain 39.03% below their 52-week high of EUR181.70. About Target Corporation Target Corporation, founded in 1902 and headquartered in Minneapolis,…

Read More

Arcturus Therapeutics Soars 23%: Investors Bet On Success

(VIANEWS) – Arcturus Therapeutics’ (NASDAQ: ARCT) shares surged 23.09% to EUR23.88 at 21:33 EST on Wednesday, following their upward trajectory since Tuesday’s session and as the stock market as a whole showed positivity – rising 0.24% overall and reaching EUR14,128.19! Arcturus Therapeutics closed at EUR19.40 on November 25, 48.61% below its 52-week high of EUR37.75….

Read More